欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SE/H/0940/001
药品名称Quatriga Perifer
活性成分
    • alanine 4.4 g
    • arginine 3.8 g
    • calcium chloride dihydrate 0.18 g
    • fish oil, rich in omega 3-acids 4.2 g
    • glucose monohydrate 71.0 g
    • glycine 3.5 g
    • histidine 0.93 g
    • isoleucine 1.6 g
    • leucine 2.3 g
    • lysine acetate 2.1 g
    • magnesium sulfate 0.38 g
    • medium-chain triglycerides 8.5 g
    • methionine 1.3 g
    • olive oil monohydrate 7.0 g
    • phenylalanine 1.6 g
    • potassium chloride 1.4 g
    • proline 3.5 g
    • serine 2.1 g
    • sodium acetate 1.1 g
    • sodium glycerophosphate hydrate 1.3 g
    • soybean oil monohydrate 8.5 g
    • taurine 0.32 g
    • threonine 1.4 g
    • tryptophan 0.63 g
    • tyrosine 0.12 g
    • valine 2.0 g
    • zinc sulfate 0.0 g
剂型Emulsion for infusion
上市许可持有人Fresenius Kabi AB 751 74 Uppsala Sweden
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Italy (IT)
许可日期2010/03/02
最近更新日期2024/04/16
药物ATC编码
    • B05BA10 combinations
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase